InvestorsHub Logo
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 992

Friday, 11/19/2021 9:12:59 AM

Friday, November 19, 2021 9:12:59 AM

Post# of 1168
Mavacamten PDUFA extended 3mo to 4/28/22:

https://www.businesswire.com/news/home/20211119005267/en

The FDA simply needs more time to complete the NDA review—it has not requested any new data or analyses from BMY.

Mavacamten is the drug BMY got in the $13.1B acquisition of MYOK in Oct 2020 (#msg-158698900).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News